Subscribe To
vericel reports second quarter 2023 financial results and raises full-year 2023 financial guidance
Record Second Quarter Total Revenue of $45.9 Million, Representing 24% Growth versus Prior Year MACI Revenue Growth of 27% to $36.3 Million Epicel Rev...
August 2, 2023, 11:55 am
vericel: multiyear growth catalysts, proprietary solutions will drive market cap expansion
vericel Corporation demonstrates consistent growth in its core product lines, including MACI for cartil...
June 27, 2023, 10:57 pm
vericel corporation (vcel) reports q1 loss, tops revenue estimates
vericel Corporation (VCEL) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus...
May 10, 2023, 10:41 am
vericel to report first-quarter 2023 financial results on may 10, 2023
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- vericel Corporation (NASDAQ:VCEL), a leader in adv...
April 26, 2023, 8:30 am
vericel corporation: a promising future in advanced cell therapies
The FDA's recent approval of NexoBrid for the treatment of burns is expected to drive revenue growth in 2023. ...
April 2, 2023, 9:14 am
vericel corporation (vcel) q4 2022 earnings call transcript
vericel Corporation (NASDAQ:VCEL ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Compan...
February 23, 2023, 2:55 pm
vericel to report fourth-quarter 2022 financial results on february 23, 2023
CAMBRIDGE, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) — vericel Corporation (NASDAQ:VCEL), a leader in adv...
February 9, 2023, 1:00 pm
vericel corporation (vcel) surges 16.3%: is this an indication of further gains?
vericel Corporation (VCEL) saw its shares surge in the last session with trading volume being higher th...
January 12, 2023, 12:00 am
Biopharma co.’s burn tissue removal product approved
Source: Swayampakula Ramakanth (1/4/23) Because of the green light from the U.S. Food and Drug Administration, H.C. Wainwright & Co. raised its target...
January 6, 2023, 2:48 pm
vericel to present at the 41st annual j.p. morgan healthcare conference on wednesday, january 11, 2023
CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- vericel Corporation (NASDAQ:VCEL), a leader in adva...
January 4, 2023, 8:34 am
vericel: aggressive growth in 2023
Various ongoing fundamental improvements signal significant upsides. The recent NexoBrid approval foretells leaping sales growth in the coming quarter...
January 1, 2023, 6:00 am
vericel announces fda approval of nexobrid for the treatment of severe thermal burns in adults
Potential to become the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns Label supported by...
December 29, 2022, 6:45 pm
vericel corp (vcel) ceo dominick colangelo on q1 2022 results - earnings call transcript
vericel Corp (NASDAQ:VCEL ) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participant...
May 4, 2022, 5:31 pm
vericel: poised for growth
The NexoBrid complete response letter sparked a market overreaction on vericel Corporation stocks. Coup...
April 17, 2022, 8:49 am
vericel - a disruptive business with years of growth remaining
vericel is a high growth, disruptive medical technology company with average 5-year sales growth of 24%...
April 12, 2022, 11:34 am
vericel corporation (vcel) ceo nick colangelo on q4 2021 results - earnings call transcript
vericel Corporation (VCEL) CEO Nick Colangelo on Q4 2021 Results - Earnings Call Transcript...
February 24, 2022, 2:10 pm
vericel corporation (vcel) ceo nick colangelo on q4 2021 results - earnings call transcript
vericel Corporation (VCEL) CEO Nick Colangelo on Q4 2021 Results - Earnings Call Transcript...
February 24, 2022, 2:10 pm
vericel corporation (vcel) ceo nick colangelo on q4 2021 results - earnings call transcript
vericel Corporation (VCEL) CEO Nick Colangelo on Q4 2021 Results - Earnings Call Transcript...
February 24, 2022, 2:10 pm